Strategy
Portfolio
People
Careers
April 6, 2017
Adaptimmune raises $106M for pipeline work; KaloBios chief says biotech is on track for Chagas drug filing
Back
Portfolio News
Next
Back
Blog
Next
News
Blog
Foresite Labs
Contact Us
Home
Strategy
Portfolio
People
Careers
News
Blog
Foresite Labs
Contact
Investor Login
Terms
Privacy Policy
©2022 Foresite Capital Management, LLC
Site by Goodlab